STCBIO

Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

March 11, 2020NewsBy stcbio

STRI (Stem Cell Treatment & Research Institute), US Patent Registration of the Nerve Cell Differentiation Technology of nEPS (newly Elicited Pluripotent Stem Cell without Side Effects by natural compounds)

[한국경제] 2019.03.28

STRI (Stem Cell Treatment & Research Institute), US Patent Registration of the Nerve Cell Differentiation Technology of nEPS (newly Elicited Pluripotent Stem Cell without Side Effects by natural compounds)
View Detail: https://www.hankyung.com/society/article/201903286415a

BACK

No title
July 31, 2020

STRI PERFECTS STEM-CELL PLURIPOTENCY TO ENABLE 3D PRINTING OF HUMAN ORGANS
April 17, 2020

460 patents regarding nEPS are registered in 147 countries.
March 19, 2020

STRI registered a patent for liver cell differentiation using the world’s first pluripotent stem cells without side effects (nEPS) at EU
March 11, 2020

STRI achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects using natural compounds(nEPS)’ at EU
March 11, 2020

bBHC achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects by natural compounds(nEPS)’ in the EU followed by Korea, America, and Australia.
March 11, 2020